香港交易及結算所有限公司、香港聯合交易所有限公司（「聯交所」）及香港中央結算有限公司 （「香港結算」）對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表 示概不會就本公告全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 除本公告另有界定者外，本公告所用詞彙與安徽金岩高嶺土新材料股份有限公司（「本公司」）所 刊發日期為2025年11月25日的招股章程（「招股章程」）所界定者具有相同涵義。 本公告不會直接或間接於或向美國（包括美國的領土及屬地、美國任何州以及哥倫比亞特區）發 佈、刊發或派發。本公告並不構成亦不屬於在香港、美國或於任何其他司法權區購買或認購證 券的任何要約或招攬的一部分。發售股份並無亦不會根據《1933年美國證券法》（經不時修訂） （「美國證券法」）登記。發售股份不得在美國境內提呈發售、出售、質押或以其他方式轉讓，惟 根據美國證券法的登記規定獲豁免者或毋須遵守有關規定的交易除外。不會在美國公開發售發 售股份。發售股份根據美國證券法S規例以離岸交易方式在美國境外提呈發售及出售。 就全球發售而言，國元融資（香港）有限公司及民銀資本有限公司擔任聯席保薦人；國元證券 ...

香港交易及結算所有限公司、香港聯合交易所有限公司（「聯交所」）及香港中央結算有限公司 （「香港結算」）對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表 示，概不對因本公告全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何 責任。 本公告僅供參考，並不構成收購、購買或認購本公司證券的邀請或要約。本公告並非招股章 程。潛在投資者於決定是否投資於由此提呈發售的H股前，應細閱上海寶濟藥業股份有限公司 （「本公司」）日期為2025年12月2日的招股章程（「招股章程」）以了解下文所述有關全球發售的詳 細資料。投資者應僅依賴招股章程所載資料作出有關發售股份的任何投資決定。 除本公告另有界定者外，本公告所用詞彙與招股章程所界定者具備相同涵義。 發售股份的潛在投資者務請注意，倘於上市日期（目前預期為2025年12月10日（星期三））上午 八時正（香港時間）之前任何時間發生招股章程「包銷 － 包銷安排及開支 － 香港公開發售 － 終 止理由」一節所載任何事件，整體協調人（為其本身及代表香港包銷商）有權立即終止其根據香 港包銷協議須承擔的責任。 1 Shanghai Bao Pharmaceuti ...

Group 1 - The company, Hebei Haiwei Electronic Materials Technology Co., Ltd., announced the results of its global offering, with a final issue price set at HKD 14.28 per share and a total of 35,456,000 H-shares offered, including an additional 4,624,600 shares due to the exercise of the over-allotment option [1] - The total proceeds from the global offering are approximately HKD 510 million, with a net amount of about HKD 450 million after estimated listing expenses [1] - The Hong Kong public offering received 165,803 valid applications, resulting in an oversubscription of 5,426.27 times, with 3,545,600 shares allocated, representing 10% of the total shares offered [1] Group 2 - The international placement had a subscription multiple of 6.11 times (before considering the over-allotment option), with 31,910,400 shares allocated, accounting for 90% of the total offering [1] - The cornerstone investor, Huixinglihai, was allocated 15,129,000 shares, which is 42.67% of the total shares offered, with a lock-up period of 6 months post-listing, ending on May 27, 2026 [1] - The exclusive sponsor for this issuance is China International Capital Corporation Hong Kong Securities Limited, with other coordinating and joint global coordinators including CITIC Securities and Bank of China International [2]

Core Viewpoint - Haiwei Co., Ltd. has successfully completed its global offering, raising approximately HKD 452 million through the issuance of 35.256 million shares at a price of HKD 14.28 per share [1] Summary by Category Offering Details - The global offering consisted of 35.256 million shares, with 10% allocated to the Hong Kong public offering and 90% to international offering [1] - The expected trading start date for H-shares on the Hong Kong Stock Exchange is November 28, 2025, at 9:00 AM Hong Kong time [1] Subscription Demand - The Hong Kong public offering was oversubscribed by 5,426.27 times, indicating strong local investor interest [1] - The international offering was oversubscribed by 6.11 times, reflecting robust demand from international investors [1]

Core Viewpoint - The company, Haiwei Co., Ltd. (09609.HK), announced a global offering of 35,456,000 H-shares at a price of HKD 14.28 per share, with net proceeds amounting to HKD 452 million [1] Summary by Category Offering Details - The Hong Kong public offering accounts for 10% of the total global offering, with a subscription rate of 5,426.27 times [1] - The international offering constitutes 90% of the total global offering, with a subscription rate of 6.11 times [1] Trading Information - If the global offering becomes unconditional by November 28, 2025, trading of the H-shares is expected to commence on the Hong Kong Stock Exchange at 9:00 AM (Hong Kong time) on the same day [1] - H-shares will be traded in lots of 200 shares, with the stock code being 9609 [1]

Core Points - LeShuShi Limited (stock code: 2698) has set its final IPO price at HKD 26.20 per share, at the upper limit of the offering range [1] - The global offering consists of 90,884,000 shares, with an overallotment option of 13,632,600 shares, potentially increasing the total to 104,516,600 shares [1] - The total fundraising amount is HKD 2.381 billion, with a net amount of approximately HKD 2.229 billion after deducting issuance costs [1] Subscription Details - The Hong Kong public offering was oversubscribed by 1,813.77 times, with 294,053 valid applications and 41,428 successful allocations [1] - The international placement was oversubscribed by 34.33 times, attracting 277 participants [1] - The final allocation was 10% for the Hong Kong offering (9,088,400 shares) and 90% for the international placement (81,795,600 shares) [1] Cornerstone Investors - The offering received backing from 21 cornerstone investors, including notable institutions such as BA Sprout, Arc Avenue Asset Management, Southern Fund, and Franklin Templeton [2] - Arc Avenue was allocated 5,929,400 shares (6.52% of the offering), while BA Sprout received 4,447,000 shares (4.89%) [2] - The total shares subscribed by cornerstone investors amounted to 41,207,400 shares, representing 6.80% of the total offering, with a lock-up period of six months until May 9, 2026 [2] Listing Information - The joint sponsors for the offering are China International Capital Corporation Hong Kong Securities Limited, CITIC Securities (Hong Kong) Limited, and GF Securities (Hong Kong) Limited [2] - Shares are expected to be listed on the Hong Kong Stock Exchange on November 10, 2025, with a minimum trading unit of 200 shares and an entry fee of approximately HKD 5,293.47 [2]

Group 1 - The company, Junsheng Electronics, announced a global offering of 155.1 million H-shares, with 10% allocated for public offering in Hong Kong and 90% for international offering [1] - The final offering price is set at HKD 22.00 per share, with net proceeds from the global offering amounting to approximately HKD 3.2525 billion [1] - The Hong Kong public offering was oversubscribed by 147.67 times, while the international offering was oversubscribed by 9.78 times [1] Group 2 - The H-shares are expected to commence trading on the Hong Kong Stock Exchange on November 6, 2025, at 9:00 AM [1]

Group 1 - The company announced the results of its share placement, with a total global offering of 17.5978 million H-shares [1] - The final offer price was set at HKD 33.370 per share, resulting in net proceeds of approximately HKD 527 million from the global offering [1] - The Hong Kong public offering was oversubscribed by 6,238.42 times, while the international offering was oversubscribed by 16.87 times [1] Group 2 - The Hong Kong public offering accounted for 10% of the total shares, while the international offering made up 90% [1] - Each board lot consists of 200 shares, and trading of the H-shares is expected to commence on November 6, 2025 [1]

Core Points - Sais Group Co., Ltd. has set the final offer price for its global issuance at HKD 131.50 per share [1] - The total number of H shares issued in this global offering is 108,619,000, with 10% allocated for public offering in Hong Kong and 90% for international placement [1] - The total funds raised from this issuance amount to approximately HKD 14.28 billion, with a net amount of about HKD 14.02 billion after deducting listing expenses [1] Public Offering - The Hong Kong public offering received strong investor interest, with a total of 202,321 valid applications, resulting in an oversubscription of 132.68 times [1] - A total of 10,861,900 shares were allocated to the public offering segment [1] International Placement - The international placement attracted 234 participants, with an oversubscription of 8.61 times, leading to the allocation of 97,757,100 shares [1] - Due to the enthusiastic response from the public offering, the company exercised its option to adjust the offering volume, issuing an additional 8,419,000 shares [2] Cornerstone Investors - The offering includes a strong lineup of cornerstone investors, with 20 institutions and individuals participating, collectively receiving 48,828,700 shares, which is 44.95% of the total global offering [2] - Notable allocations include 16,553,200 shares to the Chongqing Industry Mother Fund, representing 15.24% of the total [2] Listing Information - The H shares of Sais Group are expected to be listed on the Hong Kong Stock Exchange on November 5, 2025, under the stock code 9927, with a trading unit of 100 shares [2] - The company has applied for a waiver from the requirement to allocate shares to existing minority shareholders, allowing some existing shareholders to participate as cornerstone investors or underwriters [2]

Core Viewpoint - The company reported mixed financial results for Q3 2025, with revenue growth but a decline in net profit, and is preparing for the launch of its H-shares on the Hong Kong Stock Exchange [1][2]. Financial Performance - In Q3 2025, the company achieved revenue of 48.133 billion yuan, a year-on-year increase of 15.75%, while net profit attributable to shareholders was 2.371 billion yuan, down 1.74% [1]. - For the first three quarters of 2025, the company reported total revenue of 110.534 billion yuan, up 3.67%, and net profit attributable to shareholders of 5.312 billion yuan, an increase of 31.56% [1]. H-share Offering - The maximum offering price for the H-shares is set at 131.50 HKD per share, with additional fees, and a total of 100,200,000 H-shares will be offered globally [2][3]. - The company anticipates raising a net amount of approximately 12.9249 billion HKD, which will be allocated for R&D, new marketing channels, overseas sales, charging network services, and general corporate purposes [3].